Covered recipient · General Payments record
HILARY H WASHINGTON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$4,060.30
- Reported across 213 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $400.17 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $258.86 | 4 |
| Lilly USA, LLC | $55.65 | 2 |
| Novo Nordisk AS | $48.15 | 3 |
| Abbott Laboratories | $21.07 | 1 |
| PFIZER INC. | $16.44 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $21.07 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124800424 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.57 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105586060 | CMS |
| AstraZeneca Pharmaceuticals LP | $118.05 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104435007 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.63 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104749752 | CMS |
| AstraZeneca Pharmaceuticals LP | $103.61 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104358813 | CMS |
| Lilly USA, LLC | $26.31 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135020456 | CMS |
| Lilly USA, LLC | $29.34 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135001228 | CMS |
| Novo Nordisk Inc | $17.13 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096755494 | CMS |
| Novo Nordisk Inc | $16.18 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096910099 | CMS |
| Novo Nordisk Inc | $14.84 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097661190 | CMS |
| PFIZER INC. | $16.44 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131006735 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.